The Structural Disease Center

Filter Your Results

 

News

 

RESPECT Data Support St. Jude Medical’s Amplatzer PFO Occluder to Prevent Recurrent Ischemic Stroke

November 1, 2016 -- Final results from the RESPECT trial found that percutaneous closure of a patent foramen ovale (PFO) using the Amplatzer PFO occluder device (St.…

FDA Approves St. Jude Medical’s Amplatzer PFO Occluder

October 28, 2016 -- St. Jude Medical, Inc. announced US Food and Drug Administration (FDA) approval and the launch of the Amplatzer patent foramen ovale (PFO) occluder in the …

FDA Approves St. Jude Medical’s Amplatzer PFO Occluder

October 28, 2016 -- St. Jude Medical, Inc. announced US Food and Drug Administration (FDA) approval and the United States launch of the Amplatzer patent foramen ovale (PFO) oc…

Pediatric Trial Begins for St. Jude Medical’s Amplatzer Duct Occluder II AS for Closure of Small Patent Ductus Arteriosus

October 18, 2016 -- St. Jude Medical, Inc. announced the launch of the ADO II AS (Amplatzer Duct Occluder II Additional Sizes) pediatric clinical trial. The United States inve…

Radial Access for Structural Intervention

Kintur Sanghvi, MD; Richard Kovach, MD; and Tejas Patel, MD

September/October 2016—A transradial approach can be utilized as a primary or secondary access strategy to reduce morbidity and major adverse cardiac events in various structural interventions.

SentreHeart Closes $35 Million Funding Round for aMAZE Trial

October 3, 2016 -- SentreHeart, Inc., the manufacturer of the Lariat technology for catheter-based, nonimplant left atrial appendage closure (LAAC), recently announced that it…

Global Amplatzer Amulet IDE Trial Evaluates St. Jude Medical’s Next-Generation LAA Occluder

September 6, 2016 -- St. Jude Medical, Inc. announced last week the start of an investigational device exemption (IDE) trial that will evaluate the safety and effectiveness of…

CMS Approves LAAO Registry

August 18, 2016 -- The American College of Cardiology (ACC) and the Society for Cardiovascular Angiography and Interventions (SCAI) advised that the LAAO Registry has been ide…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.